Newborn screening platform for lysosomal storage disorders with FDA clearance and CE mark

SEEKER is a high throughput laboratory solution that quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens. Reduced activity of these enzymes may be indicative of:

Mucopolysaccharidosis Type I (MPS I), Pompe, Gaucher or Fabry disease

SEEKER Features:

  • Flexible
  • Cost-effective
  • Fast results
  • Simple operation

Based on 0 reviews

0.0 overall
0
0
0
0
0

Only logged in customers who have purchased this product may leave a review.

There are no reviews yet.